Literature DB >> 8951891

[Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis].

E Oda1, Y Ohashi, K Tashiro, Y Mizuno, H Kowa, N Yanagisawa.   

Abstract

The Modified Norris Scale is a rating scale for amyotrophic lateral sclerosis (ALS), which consists of two parts, the Limb Norris Scale and the Norris Bulbar Scale. The Limb Scale has 21 items to evaluate extremity function and the Bulbar Scale has 13 items to evaluate bulbar function. Each item is rated in 4 ordinal categories. Considering the habitual difference, we translated the English scale into Japanese one with minor modification, and added more detailed explanations for all categories of each item. Then we examined reliability and factorial structure of the translated scale. The subjects were 23 patients with motor disturbance and each subject was rated twice by 2-4 neurologists. As a measure of reliability, the Kappa coefficient proposed by Cohen (1960) and Kraemer (1980) was calculated for each item and the intraclass correlation coefficient (ICC) was evaluated for total scores of each of two scales. To analyze the factorial structure, the factor analysis was carried out. The minimum and the maximum Kappa values were .70 and .97 for intra-rater reliability of the Limb Scale's items, .60 and .83 for inter-rater reliability of the Limb Scale's items, .41 and 1.00 for intra-rater reliability of the Bulbar Scale's items and .26 and .81 for inter-rater reliability of the Bulbar Scale's items, respectively. Concerning the factorial structure, the contribution of the first factor was 83.6% for the Limb Scale and that for the Bulbar Scale was 66.7%. This indicates unidimensionality of both Scales. The ICCs for the total scores were .97 (95%C.I. .95-.99) for the Limb Scale and .86 (.73-.93) for the Bulbar Scale, respectively. On the basis of these results, the Scale has unidimensionality and high reliability enough for practical use.

Entities:  

Mesh:

Year:  1996        PMID: 8951891

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  6 in total

1.  Timing of Communication Device Introduction Defined by ALSFRS-R Score in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Ayumi Nobematsu; Kayoko Takahashi
Journal:  Prog Rehabil Med       Date:  2020-06-27

2.  A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Christopher Grunseich; Angela Kokkinis; Akihiro Hirakawa; Hirohisa Watanabe; Masahiko Yamamoto; Kenneth H Fischbeck; Gen Sobue
Journal:  Neuromuscul Disord       Date:  2015-03-20       Impact factor: 4.296

3.  Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Anna Sobuś; Agnieszka Wełnicka; Agnieszka Meller; Karolina Machowska-Sempruch; Alicja Zawiślak; Karolina Łuczkowska; Sławomir Milczarek; Bogumiła Osękowska; Edyta Paczkowska; Iwona Rotter; Przemysław Nowacki; Bogusław Machaliński
Journal:  Stem Cells Int       Date:  2019-06-02       Impact factor: 5.443

4.  Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.

Authors:  Koji Abe; Yasuto Itoyama; Gen Sobue; Shoji Tsuji; Masashi Aoki; Manabu Doyu; Chikuma Hamada; Kazuoki Kondo; Takatomo Yoneoka; Makoto Akimoto; Hiide Yoshino
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-06       Impact factor: 4.092

5.  Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.

Authors:  Bartłomiej Baumert; Anna Sobuś; Monika Gołąb-Janowska; Zofia Ulańczyk; Edyta Paczkowska; Karolina Łuczkowska; Alicja Zawiślak; Sławomir Milczarek; Bogumiła Osękowska; Agnieszka Meller; Karolina Machowska-Sempruch; Agnieszka Wełnicka; Krzysztof Safranow; Przemysław Nowacki; Bogusław Machaliński
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923

6.  A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis.

Authors:  Emily Beswick; Deborah Forbes; Zack Hassan; Charis Wong; Judith Newton; Alan Carson; Sharon Abrahams; Siddharthan Chandran; Suvankar Pal
Journal:  J Neurol       Date:  2021-06-13       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.